February 2022

Synthesis of Arylethylamines via C(sp3)–C(sp3) Palladium-Catalyzed Cross-Coupling

Research published in The Journal of Organic Chemistry, from Lippa, R. et al., has shown the access to substituted arylethylamines that are key structural components in natural, pharmaceutical, and agrochemical compounds. Substituted phenylethylamine and structurally related analogues represent a key pharmacophore found in endogenous and synthetic neurotransmitters, pharmaceutical agents, and agrochemical products including products such […]

Synthesis of Arylethylamines via C(sp3)–C(sp3) Palladium-Catalyzed Cross-Coupling Read More »

Frontier Specialty Chemicals develops and provides process to produce active pharmaceutical ingredient for clinical trial of COVID-19 therapeutic investigational drug RBT-9

Frontier Specialty Chemicals develops and provides process to produce active pharmaceuticalingredient for clinical trial of COVID-19 therapeutic investigational drug RBT-9 June 23, 2020 | Press Release Link to Story on KSLTV: ―Renibus Therapeutics Will Conduct Phase 2 Trial of Compound with Antiviral andImmune-Modulating Activity to treat effects of COVID-19 ― Logan, UT – June 23,

Frontier Specialty Chemicals develops and provides process to produce active pharmaceutical ingredient for clinical trial of COVID-19 therapeutic investigational drug RBT-9 Read More »

Shopping Cart
Scroll to Top